Oral T/tlando

  1. madman

    Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada

    It's coming! https://ir.lipocine.com/2025-06-09-Lipocine-Announces-Filing-of-New-Drug-Submission-for-TLANDO-R-in-Canada New Drug Submission filed by Lipocine's licensing partner Verity Pharma Over 700,000 total prescriptions written annually for testosterone replacement therapy (TRT) in...
  2. madman

    Lipocine Announces License and Supply Agreement for TLANDO® in Brazil

    https://ir.lipocine.com/2025-05-06-Lipocine-Announces-License-and-Supply-Agreement-for-TLANDO-R-in-Brazil SALT LAKE CITY, May 6, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of...
  3. madman

    Impact of Oral TU (Tlando) on Blood Test Profiles in Men with Hypogonadism

    * Our initial experience with TLANDO TU capsules for the treatment of hypogonadism shows it is safe and efficacious with unique post treatment blood test changes, including a decrease in SHBG in both groups. * Interestingly, while calculated free testosterone did not change in the “previous...
  4. madman

    Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea

    https://www.prnewswire.com/news-releases/lipocine-announces-distribution-and-license-agreement-with-spc-korea-to-commercialize-tlando-in-south-korea-302292252.html SALT LAKE CITY, Oct. 31, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary...
Back
Top